Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome

OBJECTIVE: To investigate the efficacy of combined modality therapy for neuroblastoma in children associated with opsoclonus-myoclonus syndrome (OMS-NB)

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 52(2014), 7 vom: 15. Juli, Seite 540-3
1. Verfasser: Zhao, Weihong (VerfasserIn)
Weitere Verfasser: Sun, Qing, Xie, Yao, Hua, Ying, Xiong, Hui, Jia, Jun, Lu, Xintian
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:English Abstract Journal Article Antineoplastic Agents Biomarkers
LEADER 01000caa a22002652c 4500
001 NLM241928982
003 DE-627
005 20250217122144.0
007 tu
008 231224s2014 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0806.xml 
035 |a (DE-627)NLM241928982 
035 |a (NLM)25224062 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Zhao, Weihong  |e verfasserin  |4 aut 
245 1 0 |a Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 13.01.2015 
500 |a Date Revised 07.06.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To investigate the efficacy of combined modality therapy for neuroblastoma in children associated with opsoclonus-myoclonus syndrome (OMS-NB) 
520 |a METHOD: From May 2011 to December 2013, 6 consecutive patients (4 boys and 2 girls) diagnosed as OMS-NB underwent surgery and chemotherapy in the First Hospital, Peking University. The median age of onset was 19.5 months (range 13-24 months) and misdiagnosis occurred 7.5 months (range 2-14 months) ago. A retrospective analysis for the location, stage, pathological type, treatment way and outcome of neuroblastoma was done 
520 |a RESULT: (1) All patients were misdiagnosed as simply opsoclonus-myoclonus syndrome (OMS) at the time of onset. They had been receiving treatment with adrenocorticotropic hormone and intravenous immunoglobulin within 1-13 months.OMS-NB was diagnosed by means of enhanced abdominal CT image which was delayed to be given after the poor efficacy or relapse. (2) The primary tumors were almost all small, stage I-II, located in adrenal, retroperitoneal or pelvis. The pathology of tumors included ganglioneuroblastoma (5/6) and neuroblastoma (1/6). (3) All these cases underwent surgery, 4/6 cases with complete tumor resection, 2/6 cases with tumor around the aorta and induced local residue. Preoperative and postoperative chemotherapy was given to 2 and 5 cases, respectively. (4) The patients were followed up for 3-31 months, except 1 patient lost, the other 5 are currently surviving disease-free (3 having been at the end of chemotherapy, 1 still in chemotherapy, and another had local recurrence and is receiving radiotherapy and chemotherapy after the second operation and now also stopped taking the medicine). The symptoms of nervous system have been significantly improved during postoperative chemotherapy 
520 |a CONCLUSION: To reduce the misdiagnosis, regular CT imaging of the abdomen or pelvic should be ordered for all cases with OMS. The children with OMS-NB need to be actively treated with the combined modality therapy including surgery, chemotherapy or radiotherapy, to reduce recurrence and reduce the symptoms of nervous system 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a Antineoplastic Agents  |2 NLM 
650 7 |a Biomarkers  |2 NLM 
700 1 |a Sun, Qing  |e verfasserin  |4 aut 
700 1 |a Xie, Yao  |e verfasserin  |4 aut 
700 1 |a Hua, Ying  |e verfasserin  |4 aut 
700 1 |a Xiong, Hui  |e verfasserin  |4 aut 
700 1 |a Jia, Jun  |e verfasserin  |4 aut 
700 1 |a Lu, Xintian  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 52(2014), 7 vom: 15. Juli, Seite 540-3  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnas 
773 1 8 |g volume:52  |g year:2014  |g number:7  |g day:15  |g month:07  |g pages:540-3 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 52  |j 2014  |e 7  |b 15  |c 07  |h 540-3